These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 21454617

  • 1. Entropy increases from different sources support the high-affinity binding of the N-terminal inhibitory domains of tissue inhibitors of metalloproteinases to the catalytic domains of matrix metalloproteinases-1 and -3.
    Wu Y, Wei S, Van Doren SR, Brew K.
    J Biol Chem; 2011 May 13; 286(19):16891-9. PubMed ID: 21454617
    [Abstract] [Full Text] [Related]

  • 2. Thermodynamic Basis of Selectivity in the Interactions of Tissue Inhibitors of Metalloproteinases N-domains with Matrix Metalloproteinases-1, -3, and -14.
    Zou H, Wu Y, Brew K.
    J Biol Chem; 2016 May 20; 291(21):11348-58. PubMed ID: 27033700
    [Abstract] [Full Text] [Related]

  • 3. Matrix metalloproteinase-10 (MMP-10) interaction with tissue inhibitors of metalloproteinases TIMP-1 and TIMP-2: binding studies and crystal structure.
    Batra J, Robinson J, Soares AS, Fields AP, Radisky DC, Radisky ES.
    J Biol Chem; 2012 May 04; 287(19):15935-46. PubMed ID: 22427646
    [Abstract] [Full Text] [Related]

  • 4. Increased backbone mobility in beta-barrel enhances entropy gain driving binding of N-TIMP-1 to MMP-3.
    Arumugam S, Gao G, Patton BL, Semenchenko V, Brew K, Van Doren SR.
    J Mol Biol; 2003 Mar 28; 327(3):719-34. PubMed ID: 12634064
    [Abstract] [Full Text] [Related]

  • 5. Directed evolution of the metalloproteinase inhibitor TIMP-1 reveals that its N- and C-terminal domains cooperate in matrix metalloproteinase recognition.
    Raeeszadeh-Sarmazdeh M, Greene KA, Sankaran B, Downey GP, Radisky DC, Radisky ES.
    J Biol Chem; 2019 Jun 14; 294(24):9476-9488. PubMed ID: 31040180
    [Abstract] [Full Text] [Related]

  • 6. Protein engineering of the tissue inhibitor of metalloproteinase 1 (TIMP-1) inhibitory domain. In search of selective matrix metalloproteinase inhibitors.
    Wei S, Chen Y, Chung L, Nagase H, Brew K.
    J Biol Chem; 2003 Mar 14; 278(11):9831-4. PubMed ID: 12515831
    [Abstract] [Full Text] [Related]

  • 7. Constraining specificity in the N-domain of tissue inhibitor of metalloproteinases-1; gelatinase-selective inhibitors.
    Hamze AB, Wei S, Bahudhanapati H, Kota S, Acharya KR, Brew K.
    Protein Sci; 2007 Sep 14; 16(9):1905-13. PubMed ID: 17660250
    [Abstract] [Full Text] [Related]

  • 8. Analysis of the binding of hydroxamic acid and carboxylic acid inhibitors to the stromelysin-1 (matrix metalloproteinase-3) catalytic domain by isothermal titration calorimetry.
    Parker MH, Lunney EA, Ortwine DF, Pavlovsky AG, Humblet C, Brouillette CG.
    Biochemistry; 1999 Oct 12; 38(41):13592-601. PubMed ID: 10521266
    [Abstract] [Full Text] [Related]

  • 9. Crystal structure of the catalytic domain of matrix metalloproteinase-1 in complex with the inhibitory domain of tissue inhibitor of metalloproteinase-1.
    Iyer S, Wei S, Brew K, Acharya KR.
    J Biol Chem; 2007 Jan 05; 282(1):364-71. PubMed ID: 17050530
    [Abstract] [Full Text] [Related]

  • 10. Global orientation of bound MMP-3 and N-TIMP-1 in solution via residual dipolar couplings.
    Arumugam S, Van Doren SR.
    Biochemistry; 2003 Jul 08; 42(26):7950-8. PubMed ID: 12834347
    [Abstract] [Full Text] [Related]

  • 11. Engineering minimal tissue inhibitors of metalloproteinase targeting MMPs via gene shuffling and yeast surface display.
    Hosseini A, Kumar S, Hedin K, Raeeszadeh-Sarmazdeh M.
    Protein Sci; 2023 Dec 08; 32(12):e4795. PubMed ID: 37807423
    [Abstract] [Full Text] [Related]

  • 12. Mutational study of the amino-terminal domain of human tissue inhibitor of metalloproteinases 1 (TIMP-1) locates an inhibitory region for matrix metalloproteinases.
    Huang W, Meng Q, Suzuki K, Nagase H, Brew K.
    J Biol Chem; 1997 Aug 29; 272(35):22086-91. PubMed ID: 9268350
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of inductive effects of different concentrations of cyclosporine A on MMP-1, MMP-2, MMP-3, TIMP-1, and TIMP-2 in fetal and adult human gingival fibroblasts.
    Nazemisalman B, Sajedinejad N, Darvish S, Vahabi S, Gudarzi H.
    J Basic Clin Physiol Pharmacol; 2019 Mar 26; 30(3):. PubMed ID: 30913036
    [Abstract] [Full Text] [Related]

  • 14. Matrix metalloproteinase-10/TIMP-2 structure and analyses define conserved core interactions and diverse exosite interactions in MMP/TIMP complexes.
    Batra J, Soares AS, Mehner C, Radisky ES.
    PLoS One; 2013 Mar 26; 8(9):e75836. PubMed ID: 24073280
    [Abstract] [Full Text] [Related]

  • 15. Threonine 98, the pivotal residue of tissue inhibitor of metalloproteinases (TIMP)-1 in metalloproteinase recognition.
    Lee MH, Rapti M, Knaüper V, Murphy G.
    J Biol Chem; 2004 Apr 23; 279(17):17562-9. PubMed ID: 14734567
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Matrix metalloproteinases and their inhibitors in gastric cancer.
    Murray GI, Duncan ME, Arbuckle E, Melvin WT, Fothergill JE.
    Gut; 1998 Dec 23; 43(6):791-7. PubMed ID: 9824606
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging.
    Baker EA, Bergin FG, Leaper DJ.
    Br J Surg; 2000 Sep 23; 87(9):1215-21. PubMed ID: 10971431
    [Abstract] [Full Text] [Related]

  • 20. Increased acinar damage of salivary glands of patients with Sjögren's syndrome is paralleled by simultaneous imbalance of matrix metalloproteinase 3/tissue inhibitor of metalloproteinases 1 and matrix metalloproteinase 9/tissue inhibitor of metalloproteinases 1 ratios.
    Pérez P, Kwon YJ, Alliende C, Leyton L, Aguilera S, Molina C, Labra C, Julio M, Leyton C, González MJ.
    Arthritis Rheum; 2005 Sep 23; 52(9):2751-60. PubMed ID: 16142742
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.